Replies to post #203011 on Elite Pharmaceuticals Inc (ELTP)

[lasers]

The real litmus test for these so called non-pharmacological techs is charcoaling and every one of them fails.

Only $ELTP ADFs led by flagship SequestOx pass "superbly"

As for Teva Vantrela ER failing "orally" as well is simply "shocking".

Oh well Only $ELTP ADFs led by flagship SequestOx pass "superbly"
on all HAL testing and deserves the ADF label.

[whatdoyouseek]

"Teva's opioid not abuse-deterrent when taken orally: FDA staff"

It is an interesting comment. SequestOX has the same issue when many pills are taken at the same time. You cannot prevent someone from taking many pills. Overdose can still happen. It is interesting to see how FDA will decide. I was wondering about this issue. Should it still be called abuse-deterrent. I am hoping the FDA is ok with it. Current so called abuse-deterrent products have the same issue. Unless products start suppressing the effect of opioid when its concentration reaches a certain point in stomach, you cannot really stop overdoses. I don't think the technology is not there yet. SequestOX is a good product and prevents many forms of abuse, but not abuse by overdose. I hope the FDA give Teva a go ahead signal in this regard.